CLRB vs GPN · $20.8M cap vs P/E 24, rev $6.29B
Cellectar Biosciences Inc (CLRB) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
Global Payments Inc (GPN) is a specialty business services company listed on US.
CLRB does not have a complete income-statement cache yet.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
CLRB currently screens at market cap $20.8M. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the CLRB and GPN stock pages for the full models.
Not investment advice.